SCHEMBL7667254

SCHEMBL7667254

CC1CN(C(C=O)n2c(=O)n(C)c3nc(-c4ccccc4)ncc32)CC(C)O1

nearest known ligand 0.38

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 1/20 0.38
GAA P10253 1/20 0.38
KMT2A Q03164 1/20 0.38
TSHR P16473 4/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MAPK1 P28482 2/20 0.36
TSPO P30536 1/20 0.36
HSD17B10 Q99714 2/20 0.36
CASP1 P29466 1/20 0.34
MAPK10 P53779 1/20 0.34
CASP7 P55210 1/20 0.34
MAPT P10636 1/20 0.34
GRM2 Q14416 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7667245 0.72 GRIN1 (0.49) TSHRTSPO
SCHEMBL10369069 0.66 ADORA2B (0.52) ALDH1A1MEN1GAAKMT2ATSHR
SCHEMBL7217031 0.65 TSPO (0.48) ALDH1A1MEN1KMT2ATSHRMAPK1
SCHEMBL7210797 0.64 TSPO (0.57) ALDH1A1TSPOHSD17B10GRM2
SCHEMBL10007507 0.63 HPGD (0.45) MEN1KMT2ATSHRMAPK1TSPO
SCHEMBL10007263 0.63 HPGD (0.47) ALDH1A1MEN1KMT2ATSHRMAPK1
SCHEMBL10006720 0.63 HPGD (0.49) ALDH1A1TSHRL3MBTL1MAPK1TSPO
SCHEMBL10007314 0.61 KCNH2 (0.42) TSPO
SCHEMBL7217070 0.61 TSPO (0.53) TSHRL3MBTL1TSPOGRM2
SCHEMBL10007254 0.61 L3MBTL1 (0.44) ALDH1A1MEN1GAAKMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6372740-B1 NERVOUS SYSTEM DISORDERS, ANTIEPILEPTIC AGENTS AND ANTIDEPRESSANTS DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2002-04-16 US disclosed
EP-1036794-A1 2-ARYL-8-OXODIHYDROPURINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, MEDICINAL COMPOSITIONS CONTAINING THE SAME, AND INTERMEDIATES THEREOF Dainippon Pharmaceutical Co., Ltd. (JP) 2000-09-20 EP disclosed